Edgewise Therapeutics

Name: Edgewise Therapeutics
Address: 1715 38th Street, Boulder, CO, 80301, US
Telephone: +17202627002

Home
United States
Boulder, CO
Edgewise Therapeutics

On a mission to improve the lives of people facing serious muscle disease.

06/18/2026

We’re heading to the 2026 PPMD Annual Conference! Our team will join the muscular dystrophy global community at this 3-day gathering of families, individuals, caregivers, physicians, researchers, and industry partners. Dr. Aravindhan Veerapandiyan from the University of Arkansas will be speaking about our investigational therapy during a breakout session on Friday.

Find us at the following events:

📍Becker Brunch: June 25, 9:45 - 10:30 AM
📍Life with Becker: A Lived Experience Panel: June 25, 10:45-11:30 AM
📍Breakout Session: Beyond Dystrophin (Approved and Investigational): June 26, 3:30-4:15 PM

Stop by our table #11 to learn more about our programs.

06/16/2026

Today we announced positive top-line data from 12-week Phase 2 CIRRUS-HCM trial with EDG-7500 in obstructive and nonobstructive Hypertrophic Cardiomyopathy (HCM).

Read the press release: https://investors.edgewisetx.com/news/news-details/2026/Edgewise-Therapeutics-Announces-Positive-Top-Line-Data-from-12-Week-Phase-2-CIRRUS-HCM-Trial-with-EDG-7500-in-Obstructive-and-Nonobstructive-Hypertrophic-Cardiomyopathy-HCM/default.aspx

06/12/2026

Meet the people behind our work! ⭐️

Our cross-functional team is fueled by one another through deep collaboration, shared values, and a singular focus: developing life-changing therapies for people living with severe, rare, neuromuscular or cardiovascular disorders.

Learn from a few of our teammates as they share insights into what it’s like to be part of this movement in muscle:

06/11/2026

A successful clinical trial takes more than science – it takes extraordinary courage from the participants and their families who help turn scientific innovation into reality. As a global leader in muscle disease science, Edgewise is pioneering transformative therapies for both muscular dystrophies and serious cardiovascular conditions, two areas with high unmet need.

We extend a thank you to our participants, families, clinical site staff and investigators whose dedication to advancing care for the muscle disease community makes our work possible.

Learn more about our clinical trials here: https://edgewisetx.com/science/clinical-trials/

06/10/2026

May was an impactful month for our team. We had the privilege of joining industry peers, patient advocacy groups, individuals and caregivers, researchers, and more at various events across the globe.

We’re so grateful for the valuable conversations and connections. Here’s a recap of where we went.

06/09/2026

June is , highlighting the importance of proactive care and awareness. Becker muscular dystrophy is a progressive muscle-weakening condition that primarily affects men. We use this month to raise awareness of the power of early detection and symptom management in improving long-term outcomes.

Visit https://beckermusculardystrophy.com/ to learn more about building your care team and other proactive management options.

06/05/2026

Our Medical Science Liaison (MSL) team is in the field every day, engaging directly with health care practitioners to build and maintain ongoing meaningful connections. These interactions are more than scientific exchange; they generate critical insights about the evolving needs within the muscular dystrophy and cardiovascular communities.

We’re looking forward to continuing these important conversations at the following June cardiovascular events!

06/04/2026

Introducing Heart to Heart—a new series exploring Hypertrophic Cardiomyopathy (HCM) through conversations with the experts at Edgewise dedicated to studying it. Throughout the series, we’ll spotlight leading voices in the field, sharing their perspectives, insights, and stories.

In our first episode, Jasmine Patel, our Director of Cardiovascular Patient Advocacy, speaks with Dr. Michael Ayers, board-certified cardiologist and member of our HCM clinical development team, to discuss the fundamentals of HCM, including the two main forms of the disease.

Learn more about HCM: https://edgewisetx.com/disease-areas/cardiovascular-diseases/

06/03/2026

Kathleen DeHaven is our Senior Director of Clinical Operations, Cardiovascular, a role built on strategic vision, operational excellence, and empathy. This work requires ongoing alignment across stakeholders, a deep understanding of the site and patient experience, data-driven curiosity, and the ability to adapt quickly as circumstances evolve. Her leadership keeps our team grounded as we advance through clinical trials toward the next milestone.

Join Kathleen and others on our mission to improve the lives of individuals and families affected by serious muscle diseases. Explore careers: https://edgewisetx.com/company/careers/

Address

1715 38th Street
Boulder, CO
80301

Telephone

+17202627002

Website

http://www.edgewisetx.com/

Alerts

Be the first to know and let us send you an email when Edgewise Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Edgewise Therapeutics:

Shortcuts

Want your business to be the top-listed Engineering Company in Boulder?